Keyword: Pfizer

News

UK Overturns Pfizer Fine for Epilepsy Drug

12.06.2018 - The UK’s Competition Appeal Tribunal has overturned a fine imposed by the Competition and Markets Authority (CMA) on Pfizer and Flynn Pharma for hiking the price of an epilepsy...

News

Pfizer Under Pressure in EpiPen Shortage

04.06.2018 - Mylan is leaning on Pfizer to do more to relieve shortages of the EpiPen Auto-Injector. Although the drugmaker based in the US and the UK owns the rights to the EpiPen, which is...

News

Pfizer pays to settle US Kickback Charge

28.05.2018 - Drugs giant Pfizer is paying nearly $24 million to the US Department of Justice (DOJ) to settle allegations that its contributions to an assistance fund were kickbacks. The company...

Strategy & Management

Along the Acquisition Trail

17.04.2018 - For the global specialty chemicals sector, the past two years have been among the most exciting of the young millennium. Many mergers and acquisitions were in the spotlight in 2017...

News

Pfizer and Allogene in Cancer Therapy Pact

06.04.2018 - Pfizer and Allogene have entered into an agreement to develop allogeneic chimeric antigen receptor T cell (CAR T) therapy for treating cancer. The deal will see Pfizer take a 25%...

News

Pfizer Left Holding Consumer Health Bag

25.03.2018 - US pharmaceutical giant Pfizer said it is continuing to weigh “strategical alternatives” for its consumer healthcare arm after the two perceived prime candidates to take over the...

News

Interest in Consumer Drug Buys Waning?

06.02.2018 - Pharmaceutical companies’ interest in buying consumer health businesses is waning, with more players interested in shedding the activities than acquiring them, reports suggest...

News

Johnson & Johnson Loses Another Patent Suit

25.01.2018 - US healthcare giant Johnson & Johnson has just been handed its second defeat in patent litigation this month. On Jan. 23, a US appeals court hearing J&J’s challenge to a lower...